Reduced PACAP levels and altered PAC1 receptor expression in the brain of AD patients were detected since early stages of the progressive neurodegeneration characterized by mild cognitive impairment (Han et al., 2015). This evidence concerns the gene ADCYAP1 and Cognitive impairment.